N@N

From pills to new uses, here's what Eli Lilly's top scientist sees as the future of weight loss drugs

The article from MSN discusses insights from Eli Lilly's Chief Scientific Officer, Dan Skovronsky, on the future of weight loss drugs. Skovronsky highlights the evolution of weight loss treatments from traditional methods like diet and exercise to the development of new pharmacological options. He mentions the success of drugs like Mounjaro (tirzepatide), which not only helps in managing diabetes but also significantly aids in weight loss. The future, according to Skovronsky, involves exploring new uses for these drugs beyond diabetes and obesity, potentially treating conditions like heart disease and sleep apnea. He also touches on the potential for these medications to be used in pill form, which could make administration easier and more accessible. Additionally, there's an emphasis on understanding the long-term effects and safety of these drugs, as well as their integration into broader health management strategies.

Read the Full CNBC Article at:
[ https://www.msn.com/en-us/health/weightloss/from-pills-to-new-uses-here-s-what-eli-lilly-s-top-scientist-sees-as-the-future-of-weight-loss-drugs/ar-AA1zrDng ]